If you’ve heard about Medicare’s new GLP-1 Bridge Program, you may be wondering: “Will Medicare pay for Wegovy® in 2026?” The short answer is yes—but it depends on why you’re taking Wegovy and whether you meet the program’s...
The Health Benefits of GLP-1 Medications: More Than Weight Loss GLP-1 medications have transformed the treatment of obesity and Type 2 diabetes. While many people first hear about these medications because of their impressive weight-loss results, research has shown...
For many people, GLP-1 medications are known simply as “weight-loss injections.” While weight reduction is certainly an important benefit, research over the last several years has revealed something much more remarkable. Scientists now recognize that GLP-1...
The short answer is generally no. If you already receive coverage for a GLP-1 medication such as Ozempic® through your Medicare Part D prescription drug plan for Type 2 diabetes, you generally cannot switch to the Medicare GLP-1 Bridge Program. The Bridge Program was...
